跳至主要内容
临床试验/EUCTR2010-021869-73-NL
EUCTR2010-021869-73-NL进行中(未招募)不适用

The value of Autologous Tenocyte Implantation in patients with chronic Achilles tendinopathy: a double-blind randomised clinical trial - ATI in Achilles tendinopathy

OrthoCell Pty Ltd0 个研究点目标入组 90 人开始时间: 2010年9月22日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Clinical diagnosis chronic midportion Achilles tendinopathy
  • Age 18-55 years
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Clinical suspicion of insertional disorders , Achilles tendon rupture, plantar flexor tenosynovitis, sural nerve pathology, peroneal subluxation
  • - Condition of the Achilles tendon caused by medications such as quinolones and statins
  • - Known to have the following disorders: spondylarthropathy, gout, hyperlipidemia, rheumatoid arthritis and sarcoidosis.
  • - Presence of an infectious disease (Hepatitis B, Hepatitis C, HIV, Syphilis)
  • - A condition that prevents the patients from executing an active rehabilitation programme
  • - Patient has received an injection in the previous 12 months for this injury
  • - Patient has received surgical intervention for this injury
  • - Patient has already one site (left or right) included in this study
  • - Patient does not wish, for whatever reason, to undergo one of the two treatments
  • - Known pregnancy
  • - Nursing women

研究者

发起方
OrthoCell Pty Ltd

相似试验